Filing Details
- Accession Number:
- 0000885590-11-000016
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2011-04-11 12:10:41
- Reporting Period:
- 2011-02-28
- Filing Date:
- 2011-04-11
- Accepted Time:
- 2011-04-11 12:10:41
- Original Submission Date:
- 2011-03-03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885590 | Valeant Pharmaceuticals International Inc. | VRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1219890 | Alexander Robert Ingram | C/O 7150 Mississauga Road Mississauga A6 L5N 8M5 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, No Par Value | Disposition | 2011-02-28 | 9,872 | $40.00 | 217,724 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- These represent restricted share units which were previously reported in Table 1.
- This amendment is being filed to correct the number of restricted share units that were reported in the original filing.